Primary Diffuse Large B-cell Lymphoma of the Stomach: Prognostic factors and Outcomes in 160 Indian patients
Anjan Bandyopadhyay(KIIT University), Gurusha Bahl(Tata Memorial Hospital), Sumeet Gujral(Homi Bhabha National Institute), M.A. Muckaden(Homi Bhabha National Institute), Tanuja Shet(Tata Memorial Hospital), Reena Nair(Tata Medical Center), Manju Sengar(Homi Bhabha National Institute), Siddharth Laskar(Homi Bhabha National Institute), Hari Menon(Tata Memorial Hospital)
International Journal of Radiation Oncology*Biology*Physics
October 1, 2010
Cited by 0
Related Papers
Consolidation Radiation After Complete Remission in Hodgkin's Disease Following Six Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Chemotherapy: Is There a Need?
|Journal of Clinical Oncology|2003|202
Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey
|The Lancet Oncology|2021|170
Lymphoma of the Gastrointestinal Tract
|Unknown|2022|146
Barriers in access to oncology drugs — a global crisis
|Nature Reviews Clinical Oncology|2022|122
Common Sense Oncology: outcomes that matter
|The Lancet Oncology|2023|101